Citations per year, relative to H Klepzig H Klepzig (= 1×)
peers
Wade Thomson
Countries citing papers authored by H Klepzig
Since
Specialization
Citations
This map shows the geographic impact of H Klepzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Klepzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Klepzig more than expected).
This network shows the impact of papers produced by H Klepzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Klepzig. The network helps show where H Klepzig may publish in the future.
Co-authorship network of co-authors of H Klepzig
This figure shows the co-authorship network connecting the top 25 collaborators of H Klepzig.
A scholar is included among the top collaborators of H Klepzig based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with H Klepzig. H Klepzig is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Klepzig, H, et al.. (1989). [The spectrum of side effects of gallopamil in comparison with other calcium antagonists].. PubMed. 78 Suppl 5. 25–8.1 indexed citations
2.
Strasser, R. H., et al.. (1983). [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].. PubMed. 125(8). 156–8.4 indexed citations
3.
Jansen, Evert K. & H Klepzig. (1976). [Studies on the influence of Molsidomin on coronary heart disease (author's transl)].. PubMed. 71(47). 2072–6.11 indexed citations
4.
Klepzig, H. (1969). [Therapy with cardiac glycosides].. PubMed. 64(35). 1533–5.1 indexed citations
5.
Klepzig, H, et al.. (1967). [Cerebrospinal fluid findings following lumbosacral myelography using Dimer-X].. PubMed. 25(39). 1548–50.1 indexed citations
Reindell, H., K. Musshoff, H Klepzig, et al.. (1958). [Functional examination of the healthy and diseased heart].. PubMed. 100(19). 765–73.14 indexed citations
10.
Reindell, H. & H Klepzig. (1958). [Rest or exercise in coronary disease; changes of blood circulation subsequent to training as a basis of exercise therapy].. PubMed. 39(8). 340–61.3 indexed citations
11.
Musshoff, K., H. Reindell, H Klepzig, et al.. (1958). Zur Normgröße des gesunden Herzens*. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 88(1). 88–97.22 indexed citations
12.
Klepzig, H. (1957). [The department of cardiology].. PubMed. 936–7.3 indexed citations
13.
Reindell, H., et al.. (1956). [Oxygen equivalent, a measure for the estimation of performance range of the heart and circulation].. PubMed. 22. 108–13.10 indexed citations
14.
Klepzig, H, G. Kindermann, & H. Reindell. (1956). [Sensitivity of the athletic heart to anoxia; comparative studies of high-performance athletes, normal persons and patients with disorders of circulation regulation and of overload of the left heart].. PubMed. 45(1-2). 8–17.1 indexed citations
Reindell, H., K. Musshoff, & H Klepzig. (1956). Regulative und myogene Dilatation des Herzens. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 85(10). 385–408.14 indexed citations
Doll, E., H Klepzig, & H. Reindell. (1954). [The upper change point in the lead I, aVL and in thoracic ECG in normal persons and after effort test and in hypertension].. PubMed. 43(15-16). 567–74.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.